高级检索
当前位置: 首页 > 详情页

CancerSCEM: a database of single-cell expression map across various human cancers

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Chinese Acad Sci, Natl Genom Data Ctr, Beijing Inst Genom, Beijing 100101, Peoples R China [2]China Natl Ctr Bioinformat, Beijing 100101, Peoples R China [3]Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing 100101, Peoples R China [4]Univ Chinese Acad Sci, Beijing 100049, Peoples R China [5]Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada [6]Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing 100730, Peoples R China
出处:
ISSN:

摘要:
With the proliferating studies of human cancers by single-cell RNA sequencing technique (scRNA-seq), cellular heterogeneity, immune landscape and pathogenesis within diverse cancers have been uncovered successively. The exponential explosion of massive cancer scRNA-seq datasets in the past decade are calling for a burning demand to be integrated and processed for essential investigations in tumor microenvironment of various cancer types. To fill this gap, we developed a database of Cancer Single-cell Expression Map (CancerSCEM, https://ngdc.cncb.ac.cn/cancerscem), particularly focusing on a variety of human cancers. To date, CancerSCE version 1.0 consists of 208 cancer samples across 28 studies and 20 human cancer types. A series of uniformly and multiscale analyses for each sample were performed, including accurate cell type annotation, functional gene expressions, cell interaction network, survival analysis and etc. Plus, we visualized CancerSCEM as a user-friendly web interface for users to browse, search, online analyze and download all the metadata as well as analytical results. More importantly and unprecedentedly, the newly-constructed comprehensive online analyzing platform in CancerSCEM integrates seven analyze functions, where investigators can interactively perform cancer scRNA-seq analyses. In all, CancerSCEM paves an informative and practical way to facilitate human cancer studies, and also provides insights into clinical therapy assessments.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 生物学
小类 | 2 区 生化与分子生物学
最新[2025]版:
大类 | 2 区 生物学
小类 | 2 区 生化与分子生物学
JCR分区:
出版当年[2020]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Chinese Acad Sci, Natl Genom Data Ctr, Beijing Inst Genom, Beijing 100101, Peoples R China [2]China Natl Ctr Bioinformat, Beijing 100101, Peoples R China [3]Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing 100101, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Chinese Acad Sci, Natl Genom Data Ctr, Beijing Inst Genom, Beijing 100101, Peoples R China [2]China Natl Ctr Bioinformat, Beijing 100101, Peoples R China [3]Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing 100101, Peoples R China [4]Univ Chinese Acad Sci, Beijing 100049, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23549 今日访问量:0 总访问量:1282 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)